Literature DB >> 25670405

Predicting IVIG resistance in UK Kawasaki disease.

Sarah Davies1, Natalina Sutton1, Sarah Blackstock1, Stuart Gormley2, Clive J Hoggart3, Michael Levin2, Jethro A Herberg2.   

Abstract

The Kobayashi score (KS) predicts intravenous immunoglobulin (IVIG) resistance in Japanese children with Kawasaki disease (KD) and has been used to select patients for early corticosteroid treatment. We tested the ability of the KS to predict IVIG resistance and coronary artery abnormalities (CAA) in 78 children treated for KD in our UK centre. 19/59 children were IVIG non-responsive. This was not predicted by a high KS (11/19 IVIG non-responders, compared with 26/40 responders, had a score ≥4; p=0.77). CAA were not predicted by KS (12/20 children with CAA vs 25/39 with normal echo had a score ≥4; p=0.78). Low albumin and haemoglobin, and high C-reactive protein were significantly associated with CAA. The KS does not predict IVIG resistance or CAA in our population. This highlights the need for biomarkers to identify children at increased risk of CAA, and to select patients for anti-inflammatory treatment in addition to IVIG. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  IVIG-resistant; Kawasaki Disease; Kobayashi Score; prediction

Mesh:

Substances:

Year:  2015        PMID: 25670405     DOI: 10.1136/archdischild-2014-307397

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  37 in total

Review 1.  Use of corticosteroids during acute phase of Kawasaki disease.

Authors:  Jeong Jin Yu
Journal:  World J Clin Pediatr       Date:  2015-11-08

2.  Identification of Differentially Expressed Genes in Kawasaki Disease Patients as Potential Biomarkers for IVIG Sensitivity by Bioinformatics Analysis.

Authors:  Lan He; Youyu Sheng; Chunyun Huang; Guoying Huang
Journal:  Pediatr Cardiol       Date:  2016-05-09       Impact factor: 1.655

3.  Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.

Authors:  Judith Sánchez-Manubens; Jordi Antón; Rosa Bou; Estíbaliz Iglesias; Joan Calzada-Hernandez; Sergi Borlan; Clara Gimenez-Roca; Josefa Rivera
Journal:  Rheumatol Int       Date:  2016-05-23       Impact factor: 2.631

4.  Targeted Use of Prednisolone with Intravenous Immunoglobulin for Kawasaki Disease.

Authors:  Hidemasa Sakai; Satoru Iwashima; Shinichiro Sano; Naoe Akiyama; Eiko Nagata; Masashi Harazaki; Tetuya Fukuoka
Journal:  Clin Drug Investig       Date:  2020-12-20       Impact factor: 2.859

Review 5.  Describing Kawasaki shock syndrome: results from a retrospective study and literature review.

Authors:  Andrea Taddio; Eleonora Dei Rossi; Lorenzo Monasta; Serena Pastore; Alberto Tommasini; Loredana Lepore; Gabriele Bronzetti; Edoardo Marrani; Biancamaria D'Agata Mottolese; Gabriele Simonini; Rolando Cimaz; Alessandro Ventura
Journal:  Clin Rheumatol       Date:  2016-05-26       Impact factor: 2.980

6.  [Association between duration of fever before treatment and intravenous immunoglobulin resistance in Kawasaki disease].

Authors:  Xin Wang; Si-Lin Pan; Zhan-Hui DU; Zhi-Xian Ji; Gang Luo; Hong-Xiao Sun; Shu-Jing Ma
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-04-15

7.  Serum alanine aminotransferase level and intravenous immunoglobulin resistance in patients with kawasaki disease.

Authors:  Hiroya Masuda; Ryusuke Ae; Taka-Aki Koshimizu; Koki Kosami; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Yosikazu Nakamura
Journal:  Clin Rheumatol       Date:  2022-07-07       Impact factor: 3.650

8.  Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.

Authors:  Marianna Fabi; Laura Andreozzi; Ilaria Frabboni; Ada Dormi; Elena Corinaldesi; Francesca Lami; Cristina Cicero; Bertrand Tchana; Rosa Francavilla; Monica Sprocati; Barbara Bigucci; Claudia Balsamo; Paola Sogno Valin; Giorgia Di Fazzio; Lorenzo Iughetti; Enrico Valletta; Federico Marchetti; Andrea Donti; Marcello Lanari
Journal:  Clin Rheumatol       Date:  2020-09-16       Impact factor: 2.980

9.  Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease.

Authors:  Hiroya Masuda; Ryusuke Ae; Taka-Aki Koshimizu; Masami Matsumura; Koki Kosami; Kanako Hayashida; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Yosikazu Nakamura
Journal:  Clin Rheumatol       Date:  2021-08-07       Impact factor: 2.980

10.  Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study.

Authors:  Yukako Yoshikane; Yoshiaki Okuma; Tatsuki Miyamoto; Junichi Hashimoto; Ryuji Fukazawa; Taichi Kato; Atsuhito Takeda; Kenji Suda; Takeji Matsushita; Michiaki Hiroe; Kyoko Imanaka-Yoshida
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-05       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.